- Home
- BOF vs PMCB Comparison
BOF vs PMCB Comparison
Compare BOF & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- PMCB
- Stock Information
- Founded
- BOF 2017
- PMCB 1996
- Country
- BOF United States
- PMCB United States
- Employees
- BOF N/A
- PMCB N/A
- Industry
- BOF Packaged Foods
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BOF Consumer Staples
- PMCB Health Care
- Exchange
- BOF Nasdaq
- PMCB Nasdaq
- Market Cap
- BOF 12.5M
- PMCB 13.9M
- IPO Year
- BOF 2023
- PMCB N/A
- Fundamental
- Price
- BOF $1.74
- PMCB $1.75
- Analyst Decision
- BOF
- PMCB
- Analyst Count
- BOF 0
- PMCB 0
- Target Price
- BOF N/A
- PMCB N/A
- AVG Volume (30 Days)
- BOF 686.7K
- PMCB 56.4K
- Earning Date
- BOF 11-14-2024
- PMCB 12-13-2024
- Dividend Yield
- BOF N/A
- PMCB N/A
- EPS Growth
- BOF N/A
- PMCB N/A
- EPS
- BOF N/A
- PMCB 0.54
- Revenue
- BOF $6,489,951.00
- PMCB N/A
- Revenue This Year
- BOF N/A
- PMCB N/A
- Revenue Next Year
- BOF N/A
- PMCB N/A
- P/E Ratio
- BOF N/A
- PMCB $3.21
- Revenue Growth
- BOF 372.36
- PMCB N/A
- 52 Week Low
- BOF $0.61
- PMCB $1.39
- 52 Week High
- BOF $4.11
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- BOF 47.62
- PMCB 49.02
- Support Level
- BOF $1.67
- PMCB $1.57
- Resistance Level
- BOF $2.20
- PMCB $1.92
- Average True Range (ATR)
- BOF 0.17
- PMCB 0.16
- MACD
- BOF -0.00
- PMCB -0.01
- Stochastic Oscillator
- BOF 32.35
- PMCB 50.00
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.